Article
Effect of N-terminal and Met23 mutations on the structure and dynamics of onconase.
The Journal of biological chemistry - 13 Feb 2004
Gorbatyuk Vitaliy Y, Tsai Cheng-Kun, Chang Chi-Fon, Huang Tai-huang
Abstract excerpt
Onconase (rONC), otherwise known as ranpirnase or P-30 protein, which was initially purified from extracts of Rana pipiens oocytes and early embryos, exhibits anticancer activity both in vitro and in vivo and is in phase III clinical trials for tumor therapy. We have determined the solution NMR structure of a recombinant onconase with Met(-1), Gln1, and Leu23 residues (M-1, Q1, M23L)rONC. The 20 best solution...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
